Latest Investment News

Sarytogan Graphite Limited has received over $2 million from key investor Dias Sarsenov, advancing its share placement strategy and preparing for a pivotal board appointment. Meanwhile, a significant top-up investment from the EBRD awaits shareholder approval.

Diatreme Resources has reported a significant boost in mineral recoveries and production forecasts for its Cyclone Project in Western Australia, driven by advanced metallurgical testwork and flowsheet optimisation.

Worley has received the Full Notice to Proceed from Venture Global for Phase 2 of the CP2 LNG export project in Louisiana, marking a significant milestone following Venture Global’s Final Investment Decision.

TMK Energy has raised $6 million in a heavily oversubscribed placement led by coal seam gas experts, aiming to accelerate drilling and commercialisation at its Gurvantes XXXV project.

Core Lithium has successfully raised A$120 million through a two-tranche institutional placement, securing full funding to restart its Finniss Lithium Operation and target production by Q3 2026.

Image Resources NL has extended its prepayment facility term to December 2026 and negotiated a six-month repayment holiday to ease cashflow pressures amid a soft mineral sands market.

Novo Resources has officially listed over 25 million free-attaching options on the ASX, following its recent capital raising. These options, exercisable at 15 cents, underpin the company’s ongoing exploration ambitions across Western Australia and New South Wales.

Finder Energy has confirmed the technical feasibility of repurposing the Petrojarl I FPSO vessel for its Kuda Tasi and Jahal oil fields, setting the stage for a final investment decision by mid-2026.

Magnum Mining and Exploration is set to launch a substantial 10,000-metre auger drilling program at its Piracanjuba prospect in Brazil, aiming to define a maiden resource for its promising ionic adsorption clay rare earth element deposit.

Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.

EBR Systems marked a pivotal transition in 2025 with FDA approval of its WiSE CRT System and the initiation of U.S. commercial implants, generating $1.6 million in revenue. Despite this progress, the company reported a net loss of $48.8 million and completed a significant capital raise to support ongoing growth.

Neometals Ltd has released a positive scoping study for its Ironclad gold deposit at the Barrambie Gold Project, outlining a rapid production pathway with potential output of up to 11,000 ounces of gold within a year.